Ocular Lymphosarcoma in Cows

Ocular lymphosarcoma is cancer involving lymphoid tissue in or behind the eye. In cattle, it most often affects the tissues within the orbit rather than starting inside the eyeball itself. As the tumor expands, the eye may protrude outward, move less normally, and become exposed to drying, irritation, and corneal injury.

In many adult cows, this eye problem is one visible part of a broader disease process called bovine lymphosarcoma or bovine leukosis. A common cause of the adult form is bovine leukemia virus (BLV), although not every cow with lymphoma is BLV-related. Merck notes that orbital infiltration associated with lymphosarcoma can cause progressive bilateral exophthalmos, reduced ocular mobility, exposure keratitis, and corneal ulceration severe enough to perforate.

This condition matters because the eye changes can be dramatic, painful, and easy to notice, but the disease is often systemic. That means your vet will usually look beyond the eye and assess the whole cow, including lymph nodes, body condition, appetite, milk production, and signs involving the heart, digestive tract, uterus, or spinal canal.

For pet parents caring for a family cow or small herd, the key point is this: a bulging eye is not always pinkeye or trauma. When the eye protrudes and the cow seems uncomfortable or unwell, prompt veterinary evaluation is important.

The most important cause of lymphosarcoma in adult cattle is enzootic bovine leukosis, which is associated with bovine leukemia virus (BLV). BLV is a blood-borne retrovirus that infects lymphocytes. Most infected cattle never become visibly ill, but a smaller percentage eventually develop tumors. Cornell notes that only about 5% of infected cows go on to develop clinical lymphosarcoma.

When tumors develop, they can appear in several body sites, including the lymphoid tissue behind the eye. That is why some cows develop a protruding eyeball. Merck also explains that lymphosarcoma in cattle may be sporadic rather than BLV-associated. Sporadic forms are not caused by BLV and are classically grouped as juvenile, thymic, and cutaneous forms, usually affecting younger animals.

BLV spreads mainly when infected white blood cells are moved from one animal to another. Risk increases with reused needles, blood-contaminated instruments, rectal palpation sleeves, dehorning tools, tattooing equipment, ear-tagging devices, and some other routine management practices. Transmission may also occur through close contact involving infected cells in secretions, and fly control may help reduce risk.

For an individual cow with an eye mass, the exact cause cannot be confirmed by appearance alone. Your vet may need to sort out whether the problem is BLV-associated lymphosarcoma, a sporadic lymphoma, squamous cell carcinoma, severe infection, trauma, or another orbital disease.

Diagnosis starts with a careful farm history and physical exam. Your vet will usually assess whether the eye problem is local or part of a systemic disease. That often includes checking both eyes, eyelid closure, corneal health, ocular movement, nearby lymph nodes, body condition, temperature, and signs involving the digestive, reproductive, cardiac, or neurologic systems.

Because ocular lymphosarcoma can mimic other serious eye conditions, your vet may work through a differential list that includes trauma, infectious bovine keratoconjunctivitis, squamous cell carcinoma, abscess, and other orbital masses. Merck specifically notes that orbital lymphosarcoma causes progressive exophthalmos with reduced ocular mobility and exposure-related corneal disease.

Testing may include bloodwork, BLV ELISA or PCR, and in some cases sampling of enlarged lymph nodes or affected tissue for cytology or biopsy. A positive BLV test supports infection, but it does not by itself prove that a visible mass is lymphosarcoma. Definitive confirmation may require tissue evaluation, and in some cattle the diagnosis is confirmed after euthanasia or at necropsy.

If the cow is intended for food production, your vet will also help guide decisions about prognosis, welfare, movement, and slaughter implications. Cornell notes that carcass condemnation from lymphosarcoma is a meaningful economic issue, so early herd-level discussion can be valuable.

Prevention focuses mainly on BLV control, because there is no vaccine and no treatment that clears the virus. USDA APHIS states that preventing spread is the best way to protect the herd. The cornerstone is reducing blood transfer between animals during routine handling.

Practical steps include using a new needle for each animal, avoiding shared blood-contaminated syringes, changing rectal palpation sleeves between cows, and cleaning and disinfecting equipment used for dehorning, ear tagging, tattooing, castration, hoof work, and similar procedures. APHIS also recommends bloodless or cautery-based dehorning methods when possible and maintaining clean handling facilities.

Testing and herd planning also matter. Your vet may recommend BLV testing with ELISA or PCR, then either culling positive animals, segregating infected and non-infected groups, or using risk-based management if whole-herd removal is not practical. Purchased additions should be discussed with your vet before entry into the herd.

Not every case of bovine lymphosarcoma is preventable, because sporadic forms are not caused by BLV. Still, strong biosecurity, fly control, careful equipment hygiene, and herd testing can reduce the risk of enzootic bovine leukosis and lower the chance that a protruding eye is the first sign of a larger herd problem.